Phase I Evaluation of CDP791, a PEGylated Di-Fab′ Conjugate that Binds Vascular Endothelial Growth Factor Receptor 2

This publication has 19 references indexed in Scilit:

• Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
  Journal of Clinical Oncology, 2007
• Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI
  Magnetic Resonance in Medicine, 2006
• Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
  Journal of Clinical Oncology, 2006
• Vascular endothelial growth factors and receptors in colorectal cancer: Implications for anti-angiogenic therapy
  European Journal Of Cancer, 2006
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study
  Journal of Clinical Oncology, 2005
• Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PTK787/ZK 222584 Administered Twice Daily in Patients With Advanced Cancer
  Journal of Clinical Oncology, 2005
• Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Associated With Increased Tumor Vascularized Volume
  Journal of Clinical Oncology, 2005
• Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis
  NMR in Biomedicine, 2002
• Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)
  Journal of Biological Chemistry, 2001
• Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging
  Journal of Magnetic Resonance Imaging, 1997